Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05441670 · ClinicalTrials.gov registry record · NA

Art and Physical Therapy in Pediatric HCT

A NA study of Hematopoietic Stem Cell Transplantation and Physical Therapy, sponsored by Medical University of South Carolina.

Active
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT05441670: Active NA study of Hematopoietic Stem Cell Transplantation and Physical Therapy, sponsored by Medical University of South Carolina.

NCT05441670 is a NA study of Hematopoietic Stem Cell Transplantation and Physical Therapy that is active but no longer recruiting, run by Medical University of South Carolina. The registered enrollment target is 18 participants, below the 9,789-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05441670, a NA study of Hematopoietic Stem Cell Transplantation and Physical Therapy, is active but no longer recruiting, sponsored by Medical University of South Carolina.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare the effect of a combination of art therapy (AT) and physical therapy (PT) to PT only in children undergoing hematopoietic cell transplant (HCT). Each child will receive daily AT and PT or only PT for 5 days per week for 2 weeks. These sessions will begin approximately on day 15 following the transplant. Prior to starting the sessions and following 2-weeks of sessions, self-care and mobility skills will be measured. During each session, the following variables will be measured: heart rate variability (i.e., time between heart beats) using a small monitor on the chest (about the size of a quarter), walking distance using an accelerometer (similar to wearing a watch), and self-reported happiness and excitability. Although results cannot be guaranteed, it is expected that each group will benefit and demonstrate improvements in emotional state, self-care, and mobility skills.

Primary Outcome

Motor function within the mobility and self-care domains of the PEDI-CAT. Scaled Scores can range from 0-100 (0=less motor function in mobility and self-care, 100=optimal motor function in mobility and self-care).

Interventions

  • BEHAVIORAL Physical Therapy
  • BEHAVIORAL Art and Physical Therapy

Study Locations (1)

South Carolina

  • MUSC Shawn Jenkin's Children's Hospital - Charleston

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2022-10-12
Est. Completion 2026-12-31
Phase NA

What the registry record for NCT05441670 still lists

NCT05441670 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 9,789-participant average among 26 other Hematopoietic Stem Cell Transplantation trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Hematopoietic Stem Cell Transplantation appearing as the primary indexed condition, and to 2 interventions - of which Physical Therapy is the first listed.

NCT05441670 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT05441670 about?

NCT05441670 is a clinical study titled "Art and Physical Therapy in Pediatric HCT". The purpose of this study is to compare the effect of a combination of art therapy (AT) and physical therapy (PT) to PT only in children undergoing hematopoietic cell transplant (HCT). Each child will receive daily AT and PT or only PT for 5 days per week for 2 weeks. These sessions will begin appro...

What is the current status of trial NCT05441670?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2022-10-12. Estimated completion is 2026-12-31.

What conditions does trial NCT05441670 study?

This clinical trial studies the following conditions: Hematopoietic Stem Cell Transplantation, Physical Therapy, Art Therapy.

What interventions are being tested in trial NCT05441670?

The interventions under investigation include: Physical Therapy (BEHAVIORAL), Art and Physical Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05441670?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05441670 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hematopoietic Stem Cell Transplantation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05441670's enrollment target sits among peer trials

18 26th of 26 the lowest of 26 other Hematopoietic Stem Cell Transplantation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hematopoietic Stem Cell Transplantation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01245179 · 18 participants · Phase 1

    Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease

  • NCT01999361 · 18 participants · NA

    Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss

  • NCT02359825 · 18 participants · Phase 1

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

  • NCT02870244 · 18 participants · Phase 1

    Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05441670, the US trial registry maintained by the National Library of Medicine. NCT05441670 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.